MAP1LC3B and pancreatic neoplasm: Single MEK or HSP90 inhibition induces autophagy (marked by LC3b), and this effect is amplified with dual inhibition, suggesting HSP90 inhibition does not sensitize pancreatic cancer to MEK inhibition via autophagy suppression [51].